Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMerck & Co., Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 9 | $1.89 | $2.27 | $2.13 |
| Q2 2025 | 4 | $2.08 | $2.36 | $2.19 |
| Q3 2025 | 4 | $2.34 | $2.66 | $2.46 |
| Q4 2025 | 7 | $2.09 | $2.37 | $2.20 |
| Q1 2026 | 7 | $2.23 | $2.54 | $2.35 |
| Q2 2026 | 3 | $2.20 | $2.50 | $2.32 |
| Q3 2026 | 3 | $2.41 | $2.74 | $2.54 |
| Q4 2026 | 7 | $2.18 | $2.48 | $2.30 |
Merck & Co., Inc. Earnings Date And Information
Merck & Co., Inc. last posted its earnings results on Tuesday, February 4th, 2025. The company reported $1.72 earnings per share for the quarter, missing analysts' consensus estimates of $1.85 by $0.13. The company had revenue of 15.62 B for the quarter and had revenue of 64.17 B for the year. Merck & Co., Inc. has generated $7 earnings per share over the last year ($6.74 diluted earnings per share) and currently has a price-to-earnings ratio of 13.86. Merck & Co., Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based on prior year's report dates.
Merck & Co., Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 2024 | N/A | $1.47 | N/A | $15.48 B | $15.62 B |
| 11/06/2024 | Q3 2024 | N/A | $1.24 | N/A | $16.47 B | $16.66 B |
| 08/05/2024 | Q2 2024 | N/A | $2.15 | N/A | $15.87 B | $16.11 B |
| 05/03/2024 | Q1 2024 | N/A | $1.88 | N/A | $15.21 B | $15.78 B |
| 04/11/2024 | Q4 2023 | N/A | -$0.48 | N/A | $14.49 B | $14.63 B |
| 11/03/2023 | Q3 2023 | N/A | $1.87 | N/A | $15.30 B | $15.96 B |
| 08/07/2023 | Q2 2023 | N/A | -$2.35 | N/A | $14.44 B | $15.04 B |
| 05/05/2023 | Q1 2023 | N/A | $1.11 | N/A | $13.79 B | $14.49 B |
| 02/24/2023 | Q4 2022 | N/A | $1.19 | N/A | N/A | $13.83 B |
| 11/03/2022 | Q3 2022 | N/A | $1.28 | N/A | $14.07 B | $14.96 B |
| 08/04/2022 | Q2 2022 | N/A | $1.56 | N/A | $13.86 B | $14.59 B |
| 05/05/2022 | Q1 2022 | N/A | $1.70 | N/A | N/A | $15.90 B |
| 02/25/2022 | Q4 2021 | N/A | $1.49 | N/A | N/A | $13.52 B |
| 11/05/2021 | Q3 2021 | N/A | $1.81 | N/A | $12.32 B | $13.15 B |
| 08/09/2021 | Q2 2021 | N/A | $0.61 | N/A | $11.23 B | $11.40 B |
| 05/05/2021 | Q1 2021 | N/A | $1.26 | N/A | N/A | $10.63 B |
| 02/25/2021 | Q4 2020 | N/A | -$0.83 | N/A | N/A | $12.52 B |
| 11/05/2020 | Q3 2020 | N/A | $1.16 | N/A | $12.21 B | $10.93 B |
| 08/05/2020 | Q2 2020 | N/A | $1.19 | N/A | $10.40 B | $9.35 B |
| 05/06/2020 | Q1 2020 | N/A | $1.28 | N/A | N/A | $12.06 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Merck & Co., Inc. Earnings: FAQ's
Merck & Co., Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based offlast year's report dates.
The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online.
The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online.
Merck & Co., Inc. (:MRK) has a recorded annual revenue of $64.17 B.
Merck & Co., Inc. (:MRK) has a recorded net income of $17.12 B.Merck & Co., Inc. has generated $6.74 earnings per share over the last four quarters.
Merck & Co., Inc. (:MRK) has a price-to-earnings ratio of 13.86 and price/earnings-to-growth ratio is 0.34.